Evidence map›Paper›PMID 19066214›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.

Tie-Jun Sten Shi, Su-Xing Leslie Liu, Henrik Hammarberg, Masahiko Watanabe, Zhi-Qing David Xu, Tomas Hökfelt

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Spinal TRPC3 promotes neuropathic pain and coordinates phospholipase C-induced mechanical hypersensitivity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Phospholipase C.Advances in experimental medicine and biology · 2020
    Review
  13. Article
  14. Human Dorsal Root Ganglia.Frontiers in cellular neuroscience · 2019
    Review
  15. Article
  16. Development of an AmpliSeqFrontiers in pharmacology · 2018
    Article
  17. WenTong HuoXue Cream Can Inhibit the Reduction of the Pain-Related Molecule PLC-Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  18. Article
  19. Article
  20. Inward-rectifying KNeuroscience · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tie-Jun Sten ShiDepartment of Neuroscience, and Department of Clinical Science and Education, Section of Hand Surgery, Södersjukhuset, Karolinska Institutet, S 171 77 Stockholm, Sweden.
Su-Xing Leslie Liu
Henrik Hammarberg
Masahiko Watanabe
Zhi-Qing David Xu
Tomas Hökfelt
Hokkaido University · JPKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of neuropathic pain is a major clinical problem. This study shows expression of phospholipase ss3 (PLCss3) in mouse and human DRG neurons, mainly in small ones and mostly with a nonpeptidergic phenotype. After spared nerve injury, the pain threshold was strongly reduced, and systemic treatment of such animals with the unselective PLC inhibitor U73122 caused a rapid and long-lasting (48-h) increase in pain threshold. Thus, inhibition of PLC may provide a way to treat neuropathic pain.

Indexed as

AnimalsDisease Models, AnimalEstrenesGanglia, SpinalHumansHyperalgesiaMiceMice, Mutant StrainsPainPain ThresholdPhosphodiesterase InhibitorsPhospholipase C betaPyrrolidinonesSpinal CordSpinal Cord Injuries1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneEstrenesPhosphodiesterase InhibitorsPhospholipase C betaPyrrolidinones

Identifiers

PMID19066214
PMCPMC2604939
OpenAlexW1991563355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.